For the quarter ending 2026-03-31, PRA had -$22,440K decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net premiums earned | - | 934,236 | - | - |
| Net investment income | - | 156,498 | - | - |
| Operating Segments-Specialty Propertyand Casualty | - | 0 | - | - |
| Operating Segments-Workers Compensation Insurance Segment | - | 0 | - | - |
| Operating Segments-Segregated Portfolio Cell Reinsurance | - | 0 | - | - |
| Corporate-Operating Segments | - | 16,276 | - | - |
| Intersegment Elimination | - | 0 | - | - |
| Equity in earnings (loss) of unconsolidated subsidiaries | - | 2,946 | - | - |
| Net investment gains (losses) | - | -5,486 | - | - |
| Other income (expense) | - | -3,496 | - | - |
| Net losses and loss adjustment expenses | - | 665,418 | - | - |
| Operating expenses | - | 182,748 | - | - |
| Deferred policy acquisition costs amortization | - | 131,318 | - | - |
| Operating Segments-Specialty Propertyand Casualty | - | 0 | - | - |
| Operating Segments-Workers Compensation Insurance Segment | - | 0 | - | - |
| Operating Segments-Segregated Portfolio Cell Reinsurance | - | 2,413 | - | - |
| Corporate-Operating Segments | - | 0 | - | - |
| Intersegment Elimination | - | 0 | - | - |
| Spc u.s. federal income tax benefit (expense) | - | 2,413 | - | - |
| Operating Segments-Specialty Propertyand Casualty | - | 0 | - | - |
| Operating Segments-Workers Compensation Insurance Segment | - | 0 | - | - |
| Operating Segments-Segregated Portfolio Cell Reinsurance | - | 6,873 | - | - |
| Corporate-Operating Segments | - | 0 | - | - |
| Intersegment Elimination | - | 0 | - | - |
| Spc dividend (expense) income | - | 6,873 | - | - |
| Operating Segments-Specialty Propertyand Casualty | - | 0 | - | - |
| Operating Segments-Workers Compensation Insurance Segment | - | 0 | - | - |
| Operating Segments-Segregated Portfolio Cell Reinsurance | - | 0 | - | - |
| Corporate-Operating Segments | - | 20,838 | - | - |
| Intersegment Elimination | - | 0 | - | - |
| Interest expense | - | 20,838 | - | - |
| Operating Segments-Specialty Propertyand Casualty | - | 0 | - | - |
| Operating Segments-Workers Compensation Insurance Segment | - | 0 | - | - |
| Operating Segments-Segregated Portfolio Cell Reinsurance | - | 0 | - | - |
| Corporate-Operating Segments | - | 22,229 | - | - |
| Intersegment Elimination | - | 0 | - | - |
| Income tax benefit (expense) | - | 22,229 | - | - |
| Segment results | - | 35,142 | - | - |
| Transaction-related costs, net-Material Reconciling Items | - | -1,772 | - | - |
| Net income (loss) | 8,461 | 33,370 | 1,446 | 16,099 |
| Goodwill impairment | - | 0 | - | - |
| Depreciation and amortization, net of accretion | 2,912 | 3,018 | 3,308 | 7,363 |
| (increase) decrease in cash surrender value of boli | 454 | 441 | 928 | 1,239 |
| Gain on sale of intangible assets | - | - | 0 | 950 |
| Gain on sale of capital assets | 0 | 0 | 0 | 2,212 |
| Net investment (gains) losses | -3,425 | -4,860 | 840 | -1,466 |
| Share-based compensation | 2,271 | 1,925 | 2,059 | 3,865 |
| Deferred income tax expense (benefit) | 832 | 8,119 | 2,667 | 6,002 |
| Policy acquisition costs, net of amortization (net deferral) | 2,938 | -2,489 | 16 | 738 |
| Equity in (earnings) loss of unconsolidated subsidiaries | 2,938 | 2,946 | 4,731 | 8,599 |
| Distributed earnings from unconsolidated subsidiaries | 5,235 | 9,086 | 4,998 | 8,797 |
| Other, net | 199 | 278 | -3,105 | 560 |
| Premiums receivable | 9,754 | -27,920 | 3,204 | 24,111 |
| Reinsurance related assets and liabilities | -3,951 | -21,729 | 3,111 | -17,822 |
| Other assets | -911 | 2,159 | -2,302 | -13,532 |
| Reserve for losses and loss adjustment expenses | -38,118 | -100,541 | -15,967 | -49,225 |
| Unearned premiums | 40,352 | -54,500 | 32,825 | 6,749 |
| Other liabilities | -35,272 | 34,255 | 3,285 | -33,735 |
| Net cash provided by (used in) operating activities | -21,323 | -13,144 | 27,198 | -39,674 |
| Payments To Acquire Available For Sale Securities Debt | 220,106 | 228,250 | 188,636 | 475,583 |
| Payments To Acquire Equity Securities Fv Ni | 247 | 1,509 | 955 | 1,795 |
| Payments To Acquire | 10 | 590 | 1,900 | 570 |
| Investment in unconsolidated subsidiaries | 2,042 | 10,629 | 5,025 | 12,062 |
| Proceeds from sale of intangible assets | - | - | 0 | 950 |
| Proceeds From Sale And Maturity Of Available For Sale Securities | 234,761 | 232,763 | 200,931 | 469,789 |
| Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment | 491 | 744 | 1,477 | 25,062 |
| Proceeds From Sale And Maturity Of | 1,228 | 417 | 500 | 17 |
| Net sales or (purchases) of fixed maturities, trading | 760 | -1,882 | 695 | 2,929 |
| Return of invested capital from unconsolidated subsidiaries | 4,806 | 12,102 | 2,871 | 20,204 |
| Net sales or maturities (purchases) of short-term investments | 23,418 | -6,258 | 33,373 | 1,430 |
| Unsettled security transactions, net change | -8,382 | 10,791 | -13,204 | 1,121 |
| Purchases of capital assets | 214 | 62 | 3,155 | 381 |
| Proceeds from sale of capital assets | 0 | 0 | 0 | 19,308 |
| Net cash impact of deconsolidation of closed years of account from lloyd's syndicates operations | 0 | 0 | 0 | 11,102 |
| Other | 0 | -950 | 2 | -18 |
| Net cash provided by (used in) investing activities | 4,391 | -1,429 | -13,368 | 34,233 |
| Borrowings (repayments) under revolving credit agreement | -1,563 | -6,250 | - | - |
| Repayments of senior notes | - | 0 | - | - |
| Borrowings (repayments) under revolving credit agreement | - | - | 1,563 | 3,125 |
| Repurchase of common stock | - | 0 | - | - |
| Other | - | 0 | 0 | -2,646 |
| Dividends to shareholders | - | 0 | - | - |
| Capital contribution received from (return of capital to) external segregated portfolio cell participants | -785 | -1,828 | 585 | -2,064 |
| Net effect of restricted and performance shares issued | 3,160 | - | - | - |
| Net cash provided by (used in) financing activities | -5,508 | -3,390 | -978 | -7,835 |
| Increase (decrease) in cash and cash equivalents | -22,440 | -17,963 | 12,852 | -13,276 |
| Cash and cash equivalents at beginning of period | 36,494 | 54,457 | 54,881 | - |
| Cash and cash equivalents at end of period | 14,054 | 36,494 | 54,457 | - |
PROASSURANCE CORP (PRA)
PROASSURANCE CORP (PRA)